Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics Neoplasma 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Neoplasma Vol.52, p.388-392, 2005 |
||
Title: Pleural fluids associated with metastatic lung tumors are rich in progelatinase B/proMMP-9 | ||
Author: J., KOTYZA ; M., PESEK ; V., BEDNAROVA ; M., TERL ; B., WERLE ; | ||
Abstract: Gelatinase B/MMP-9 is a member of matrix metalloproteinases with a major role in extracellular matrix degradation, cell
proliferation and migration. Its proenzyme form has also been reported in pleural fluids as an inducible species, but its relation
to pleural pathology has not yet been fully clarified. The primary goal of this study was to evaluate proMMP-9 as a potential
marker for differentiating pleural effusions of both malignant and non-malignant origin. Pleural fluid samples were studied from 194 patients, including tumor etiology in 133 cases, inflammatory disorders in 33, transudates in 12, and unspecified disorders in 16 patients. The concentrations of proMMP-9 were estimated by means of immunoassays and/or by scanning zymography. Samples were also examined for C-reactive protein (CRP). The analysis of proMMP-9 showed significant differences among the etiological groups with the highest concentrations in parainflammatory exudates, intermediate in paraneoplastic exudates, and the lowest in transudates. However, the analysis of the paraneoplastic group revealed a distinct heterogeneity with a minor portion of fluids reaching values typical for parainflammatory effusions. A subsequent sorting based on tumor histology showed increased levels particularly in exudates associated with metastatic tumors. Interestingly, proMMP-9 values in general correlated with CRP, a systemic marker of inflammation. Thus, MMP-9 proenzyme appears to complement traditional markers distinguishing pleural fluids of different origin. Yet, the differentiation between paraneoplastic and parainflammatory exudates must be regarded with caution due to the presence of a high-expressive paraneoplastic subpopulation, including effusions associated with metastatic tumors. |
||
Keywords: MMP-9, pleural effusion, lung cancer, metastasis, C-reactive protein | ||
Year: 2005, Volume: 52, Issue: | Page From: 388, Page To: 392 | |
|
download file |
|